Exact Mass: 514.3141666
Exact Mass Matches: 514.3141666
Found 500 metabolites which its exact mass value is equals to given mass value 514.3141666
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
elatericin B
Cucurbitacin I is a cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. It has a role as a plant metabolite and an antineoplastic agent. It is a cucurbitacin and a tertiary alpha-hydroxy ketone. Cucurbitacin I is a natural product found in Elaeocarpus chinensis, Elaeocarpus hainanensis, and other organisms with data available. A cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. Cucurbitacin I is a natural selective inhibitor of JAK2/STAT3, with potent anti-cancer activity.
stigmatellin
A member of the class of chromones that is isolated from Stigmatella aurantiaca Sg a15. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
Ganoderic acid J
Ganoderic acid J is found in mushrooms. Ganoderic acid J is a metabolite of Ganoderma lucidum (reishi).
Ganoderenic acid B
Ganoderenic acid B is found in mushrooms. Ganoderenic acid B is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderenic acid B is found in mushrooms. Ganoderenic acid B is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderenic acid B exhibits potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to Doxorubicin[1].
Ganoderic acid C1
Ganoderic acid C1 is found in mushrooms. Ganoderic acid C1 is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid C1 is found in mushrooms. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Ganoderenic acid A
Ganoderenic acid A is found in mushrooms. Ganoderenic acid A is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderenic acid A is found in mushrooms. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1]. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1].
Ganoderic acid xi
Ganoderic acid xi is found in mushrooms. Ganoderic acid xi is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid xi is found in mushrooms.
Flavidulol C
Flavidulol C is found in mushrooms. Flavidulol C is isolated from the edible, but bitter tasting Japanese kihatsudake mushroom (Lactarius flavidulus). Isolated from the edible, but bitter tasting Japanese kihatsudake mushroom (Lactarius flavidulus). Flavidulol C is found in mushrooms.
Ganoderic acid V1
Ganoderic acid V1 is found in mushrooms. Ganoderic acid V1 is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Ganoderic acid V1 is found in mushrooms.
Ganosporelactone B
Ganosporelactone B is found in mushrooms. Ganosporelactone B is isolated from the spores of Ganoderma lucidum (reishi).
N-Docosahexaenoyl Tryptophan
N-docosahexaenoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Tryptophan is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Cucurbitacin I
Ganoderic acid D
Ganoderic acid C1 is a triterpenoid. Ganoderic acid C1 is a natural product found in Ganoderma lucidum with data available. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Laulimalide
A macrolide with formula C30H42O7 that is isolated from the marine sponges, Cacospongia mycofijiensis and Hyattella sp.
Ganoderic acid D
Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Anhydrocochlioquinone A
[Raw Data] CBA28_Anhydrocochlioq_pos_50eV_1-2_01_1556.txt [Raw Data] CBA28_Anhydrocochlioq_pos_40eV_1-2_01_1555.txt [Raw Data] CBA28_Anhydrocochlioq_pos_30eV_1-2_01_1554.txt [Raw Data] CBA28_Anhydrocochlioq_pos_20eV_1-2_01_1553.txt [Raw Data] CBA28_Anhydrocochlioq_pos_10eV_1-2_01_1541.txt
(17R,20S,22R)-4beta-hydroxy-1-oxo-5beta,6beta-epoxy-16alpha-acetoxywitha-2-enolide
3beta-O-(beta-D-sarmentosyl)-8,14-epoxy-5beta,14beta-card-16,20(22)-dienolide|cardenolide N-2
Cucurbitacin I
Cucurbitacin i is a member of the class of compounds known as cucurbitacins. Cucurbitacins are polycyclic compounds containing the tetracyclic cucurbitane nucleus skeleton, 19-(10->9b)-abeo-10alanost-5-ene (also known as 9b-methyl-19-nor lanosta-5-ene), with a variety of oxygenation functionalities at different positions. Cucurbitacin i is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cucurbitacin i can be found in cucumber, which makes cucurbitacin i a potential biomarker for the consumption of this food product. Cucurbitacin I is a natural selective inhibitor of JAK2/STAT3, with potent anti-cancer activity.
1,3,7-Trihydroxy-3,7-dimethyl-2-(3-methylbutanoyl)-6,6-diprenyl-2,3,3a,4,7,7a-hexahydrospiro[1-cyclohexene-4,5(6H)-[1H]indene]-3,5-dione
7??,23?鈥?Dihydroxy-3,11,15-trioxolanosta-8,20E(22)-dien-26-oic acid
(22S,24S)-16,24;22,25-dianhydro-16,22,22,24,25-pentahydroxy-2beta-methoxy-3,11-dioxocucurbit-5-ene
methyl 7beta-hydroxy-3,11,15,23-tetraoxo-5alpha-lanost-8-en-26-oate
(5alpha,6beta,18S,22R)-18,20-epoxy-6,22-dihydroxy-5,18-dimethoxy-1-oxoergosta-2,24-dien-26-oic acid delta-lactone|5-O-methoxywithaphysalin R
3,7,11,15,23-pentaoxolanostan-26-oic acid|8beta,9alpha-dihydroganoderic acid C
(17R,20S,22R)-4beta-hydroxy-1-oxo-5beta,6beta-epoxy-18-acetoxywitha-2-enolide
3??-Methoxy-16??-hydroxyursa-12,19(29)-dien-27,28-dioic acid
2alpha,3beta-dihydroxy-urs-12,19(29)-dien-28-oic acid|euscaphic acid J
12-O-tiglyl-4-deoxy-4alpha-phorbol-13-(2-methyl)butyrate
(20R)-5alpha-pregnane-2alpha,3alpha,16beta,20-tetrol 2-O-beta-D-glucopyranoside
Methyl (24E)-9??,23??-dihydroxy-3,15-dioxo-17,15-friedo-lanostan-8(14),24-dien-26-oate
3beta(H)-1-oxo-7beta,9alpha,13-triangelyloxylongipinane
2,3-seco-22,29-lactone-oleane-12-ene-2,3-dioic acid 3-methyl ester
eudesm-11-en-4alpha-O-beta-D-2-cinnamoyloxy-glucopyranoside|fissipallin
(3beta,5beta,6beta,18S,22R)-5,6:18,20-diepoxy-22-hydroxy-3,18-dimethoxy-1-oxoergost-24-en-26-oic acid delta-lactone|withaphysalin Q
(4aR)-9-((1S)-2cF-Acetoxy-1rF,3tF-dimethyl-pent-catF-yl)-3t-(alpha-hydroxy-isopropyl)-6a,12b-dimethyl-(4ar,6at,12bt)-1,2,3,4a,5,6,6a,12b-octahydro-pyrano[3,2-a]xanthen-8,11-dion|(4aR)-9-((1S)-2cF-acetoxy-1rF,3tF-dimethyl-pent-catF-yl)-3t-(alpha-hydroxy-isopropyl)-6a,12b-dimethyl-(4ar,6at,12bt)-1,2,3,4a,5,6,6a,12b-octahydro-pyrano[3,2-a]xanthene-8,11-dione|anhydroisocochlioquinone A
16-Ac-30(8鈥樏傗垎9)-Abeo-3,11,16-trihydroxyfusida-7,17(20),24-trien-21-oic acid
3,4-secocycloarta-4(28),16,24-(Z)-triene-7beta,15alpha,20beta-trihydroxy-3-oic acid|angustific acid B
(24S)-16,24-anhydro-16,24,25-trihydroxy-2beta-methoxy-3,11,22-trioxocucurbit-5-ene
Ganoderic acid LM2
Ganoderenic acid B
Ganoderenic acid B is a triterpenoid. CID 78074039 is a natural product found in Ganoderma applanatum and Ganoderma lucidum with data available. Ganoderenic acid B is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderenic acid B exhibits potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to Doxorubicin[1].
Ganoderenic acid A
Ganoderenic acid A is a triterpenoid. (E)-6-[(7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid is a natural product found in Ganoderma applanatum and Ganoderma lucidum with data available. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1]. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1].
Ganoderic acid J
C27H46O9_9,12,15-Octadecatrienoic acid, 3-(hexopyranosyloxy)-2-hydroxypropyl ester, (9Z,12Z,15Z)
Ala Ile Arg Arg
Ala Leu Arg Arg
Ala Arg Ile Arg
Ala Arg Leu Arg
Ala Arg Arg Ile
Ala Arg Arg Leu
Phe His Ile Val
C26H38N6O5 (514.2903537999999)
Phe His Leu Val
C26H38N6O5 (514.2903537999999)
Phe His Val Ile
C26H38N6O5 (514.2903537999999)
Ile Ala Arg Arg
Ile Ile Asn Arg
Ile Ile Arg Asn
Ile Leu Asn Arg
Ile Leu Arg Asn
Ile Asn Ile Arg
Ile Asn Leu Arg
Ile Asn Arg Ile
Ile Asn Arg Leu
Ile Gln Arg Val
Ile Gln Val Arg
Ile Arg Ala Arg
Ile Arg Ile Asn
Ile Arg Leu Asn
Ile Arg Asn Ile
Ile Arg Asn Leu
Ile Arg Gln Val
Ile Arg Arg Ala
Ile Arg Val Gln
Ile Val Gln Arg
Ile Val Arg Gln
Leu Ala Arg Arg
Leu Ile Asn Arg
Leu Ile Arg Asn
Leu Leu Asn Arg
Leu Leu Arg Asn
Leu Asn Ile Arg
Leu Asn Leu Arg
Leu Asn Arg Ile
Leu Asn Arg Leu
Leu Gln Arg Val
Leu Gln Val Arg
Leu Arg Ala Arg
Leu Arg Ile Asn
Leu Arg Leu Asn
Leu Arg Asn Ile
Leu Arg Asn Leu
Leu Arg Gln Val
Leu Arg Arg Ala
Leu Arg Val Gln
Leu Val Gln Arg
Leu Val Arg Gln
Asn Ile Ile Arg
Asn Ile Leu Arg
Asn Ile Arg Ile
Asn Ile Arg Leu
Asn Leu Ile Arg
Asn Leu Leu Arg
Asn Leu Arg Ile
Asn Leu Arg Leu
Asn Arg Ile Ile
Asn Arg Ile Leu
Asn Arg Leu Ile
Asn Arg Leu Leu
Pro Arg Arg Ser
C20H38N10O6 (514.2975647999999)
Pro Arg Ser Arg
C20H38N10O6 (514.2975647999999)
Pro Ser Arg Arg
C20H38N10O6 (514.2975647999999)
Gln Ile Arg Val
Gln Ile Val Arg
Gln Leu Arg Val
Gln Leu Val Arg
Gln Arg Ile Val
Gln Arg Leu Val
Gln Arg Val Ile
Gln Arg Val Leu
Gln Val Ile Arg
Gln Val Leu Arg
Gln Val Arg Ile
Gln Val Arg Leu
Arg Ala Ile Arg
Arg Ala Leu Arg
Arg Ala Arg Ile
Arg Ala Arg Leu
Arg Ile Ala Arg
Arg Ile Ile Asn
Arg Ile Leu Asn
Arg Ile Asn Ile
Arg Ile Asn Leu
Arg Ile Gln Val
Arg Ile Arg Ala
Arg Ile Val Gln
Arg Leu Ala Arg
Arg Leu Ile Asn
Arg Leu Leu Asn
Arg Leu Asn Ile
Arg Leu Asn Leu
Arg Leu Gln Val
Arg Leu Arg Ala
Arg Leu Val Gln
Arg Asn Ile Ile
Arg Asn Ile Leu
Arg Asn Leu Ile
Arg Asn Leu Leu
Arg Pro Arg Ser
C20H38N10O6 (514.2975647999999)
Arg Pro Ser Arg
C20H38N10O6 (514.2975647999999)
Arg Gln Ile Val
Arg Gln Leu Val
Arg Gln Val Ile
Arg Gln Val Leu
Arg Arg Ala Ile
Arg Arg Ala Leu
Arg Arg Ile Ala
Arg Arg Leu Ala
Arg Arg Pro Ser
C20H38N10O6 (514.2975647999999)
Arg Arg Ser Pro
C20H38N10O6 (514.2975647999999)
Arg Ser Pro Arg
C20H38N10O6 (514.2975647999999)
Arg Ser Arg Pro
C20H38N10O6 (514.2975647999999)
Arg Val Ile Gln
Arg Val Leu Gln
Arg Val Gln Ile
Arg Val Gln Leu
Ser Pro Arg Arg
C20H38N10O6 (514.2975647999999)
Ser Arg Pro Arg
C20H38N10O6 (514.2975647999999)
Ser Arg Arg Pro
C20H38N10O6 (514.2975647999999)
Val Ile Gln Arg
Val Ile Arg Gln
Val Leu Gln Arg
Val Leu Arg Gln
Val Gln Ile Arg
Val Gln Leu Arg
Val Gln Arg Ile
Val Gln Arg Leu
Val Arg Ile Gln
Val Arg Leu Gln
Val Arg Gln Ile
Val Arg Gln Leu
Ganoderic acid C
Ganoderic acid Z
Ganosporelactone B
Flavidulol C
Ganoderic acid V1
tert-butyl 1,6-diazaspiro[3.4]octane-1-carboxylate hemioxalate
17-[(E)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthrene-3,11-dione
(2Z)-2-[(3R,4S,8S,9R,10S,13R,14R,16S)-3-hydroxy-4,10,14-trimethyl-11-oxo-16-propanoyloxy-2,3,4,5,6,7,8,9,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid
3-(4-tert-butylphenyl)-1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
2-(dimethylamino)-N-[(4R,7R,8S)-5-[(2-fluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C28H39FN4O4 (514.2955185999999)
3-(4-tert-butylphenyl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-tert-butylphenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-tert-butylphenyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3S)-8-(3-hydroxyhex-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(4-tert-butylphenyl)-1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
(Z)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid
(8S,9R,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthrene-3,11-dione
[2-hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate
(2-hydroxy-3-phosphonooxypropyl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
2-[hydroxy-[2-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
eurysterol A sulfonic acid
A steroid sulfate that is 5alpha-cholestane substituted by hydroxy groups at positions 5 and 6, a bridged oxolane at positions 8 and 19 pand a sulfate group at position 3.
LPEt(22:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2r)-2-[(2r,3r,3ar,6s,7s,9br)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid
15-[1-(4,5-dimethyl-6-oxooxan-2-yl)ethyl]-6-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-14-yl acetate
(2r,5z)-6-[(1s,3as,4r,5as,7r,9ar,11as)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
(1r,2s,3as,3br,9as,9bs,11r,11as)-11-(acetyloxy)-1-[(2s)-2-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate
(2z)-6-[(1r,3s,3ar,4s,5ar,9as,11ar)-3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-2-methylhepta-2,6-dienoic acid
ethyl (6r)-6-[(1r,3ar,6s,7r,9as,11r,11ar)-7,11-dihydroxy-6,9a,11a-trimethyl-4,10-dioxo-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoate
(2s,5e)-6-[(1r,3ar,4s,5ar,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
(2r,6s)-6-[(1r,3ar,4s,5ar,9as,11ar)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
2-[(3r,4s,5s,6s,7e,9e,11e)-4,6-dimethoxy-3,5,11-trimethyltrideca-7,9,11-trien-1-yl]-8-hydroxy-5,7-dimethoxy-3-methylchromen-4-one
(2s,3s)-1-[(3s,7s,10s,13e)-10-[(2s)-butan-2-yl]-8,11-dihydroxy-16-methoxy-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-methylpentan-1-one
(2r,3r,4s,5s,6r)-2-{[(1s,2s,3as,3br,5as,7s,8r,9as,9bs,11as)-2,7-dihydroxy-1-[(1r)-1-hydroxyethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-[6-(2-carboxyethyl)-2-hydroxy-7-(3-hydroxyprop-1-en-2-yl)-3a,6,9b-trimethyl-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid
(2r,6r)-6-[(1r,3as,3br,5ar,9as,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-octahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
2-[7-ethenyl-2-hydroxy-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid
3,4-dihydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-5'',7,10-trione
5'-(1-{1-ethyl-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-6',10'-dimethyl-13'-oxaspiro[oxolane-2,11'-tetracyclo[7.5.0.0²,⁶.0¹²,¹⁴]tetradecan]-8'-ene-5,7'-dione
(6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
6-{4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxohept-5-enoic acid
2-[(1z,2s,3as,3bs,5as,6s,7r,9as,9bs,11ar)-2-(acetyloxy)-7-hydroxy-3a,3b,6,9a-tetramethyl-10-oxo-dodecahydrocyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
4,6-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-(6-hydroxy-1-benzofuran-2-yl)benzene-1,3-diol
methyl (2r,6r)-6-[(1r,3s,3ar,5ar,9as,11ar)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate
6-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-octahydro-1h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoic acid
(1r,3e,5r,7s,9r,10e,12s,13s,14r)-1-(acetyloxy)-13-hydroxy-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-9-yl (2e)-3-[(2s,3r)-3-propyloxiran-2-yl]prop-2-enoate
(3s,3as,6r,7ar)-5-{5-[(5r,6s,7as)-6-ethenyl-3-(hydroxymethyl)-6-methyl-2-oxo-4,5,7,7a-tetrahydro-1-benzofuran-5-yl]hex-5-en-2-yl}-6-ethyl-3-hydroxy-3-(hydroxymethyl)-6-methyl-7,7a-dihydro-3ah-1-benzofuran-2-one
(2r)-2-[(2r,3r,3ar,6s,7r,9br)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid
(1s,3'r,3'as,7's,7'ar)-3',4,7'-trihydroxy-3',7'-dimethyl-5,5-bis(3-methylbut-2-en-1-yl)-3-[(2r)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione
7-hydroxy-12-[1-hydroxy-3-(4-methyl-3,6-dihydro-2h-pyran-2-yl)prop-2-en-1-yl]-3-methyl-5-methylidene-9,13,22-trioxatricyclo[16.3.1.0⁸,¹⁰]docosa-15,19-dien-14-one
15-(1-{2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl}ethyl)-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-14-yl acetate
(2s,3s,4s)-2-[(2r,4ar,10ar,12ar)-2-(2-hydroxypropan-2-yl)-4a,10a-dimethyl-6,9-dioxo-2,3,4,11,12,12a-hexahydro-1,10-dioxatetraphen-8-yl]-4-methylhexan-3-yl acetate
4,4',6,12,17,17-hexamethyl-9,18,23,24-tetraoxaspiro[hexacyclo[20.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰.0¹⁶,²²]pentacosane-8,2'-oxolan]-20-ene-5',19-dione
3β-methoxy-16α-hydroxyursa-12,19(29)-dien-27,28-dioicacid
{"Ingredient_id": "HBIN008274","Ingredient_name": "3\u03b2-methoxy-16\u03b1-hydroxyursa-12,19(29)-dien-27,28-dioicacid","Alias": "NA","Ingredient_formula": "C31H46O6","Ingredient_Smile": "CC1CCC2(C(CC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC)C)C)C2C1=C)C(=O)O)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13964","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5α,8α-Peroxydehydrotumulosic acid
{"Ingredient_id": "HBIN011396","Ingredient_name": "5\u03b1,8\u03b1-Peroxydehydrotumulosic acid","Alias": "NA","Ingredient_formula": "C31H46O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C24C=CC5(C3(CCC(C5(C)C)O)C)OO4)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41112","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7β,23ξ-dihydroxy-3,11,15-trioxolanosta-8,-20e(22)-dien-26-oicacid
{"Ingredient_id": "HBIN013082","Ingredient_name": "7\u03b2,23\u03be-dihydroxy-3,11,15-trioxolanosta-8,-20e(22)-dien-26-oicacid","Alias": "NA","Ingredient_formula": "C30H42O7","Ingredient_Smile": "CC(CC(C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6167","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}